Lanean...
Tau spread, apoE, inflammation, and more: Rapidly evolving basic science in AD
To date, Alzheimer's disease (AD) drug candidates have produced negative results in human trials and progress moving new targets out of the laboratory and into trials has been slow. However, based on three decades of previous work, there is reason to hope that amyloid-based and other novel ther...
Gorde:
| Argitaratua izan da: | Neurol Clin |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5417853/ https://ncbi.nlm.nih.gov/pubmed/28410655 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ncl.2017.01.001 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|